KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Gains from Sales and Divestitures (2021 - 2025)

LifeMD filings provide 5 years of Gains from Sales and Divestitures readings, the most recent being $200000.0 for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 86.25% to $200000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $200000.0, a 86.25% decrease, with the full-year FY2025 number at $200000.0, down 86.25% from a year prior.
  • Gains from Sales and Divestitures hit $200000.0 in Q4 2025 for LifeMD, roughly flat from $200000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.5 million in Q4 2024 to a low of $26875.0 in Q2 2021.
  • Median Gains from Sales and Divestitures over the past 5 years was $120375.0 (2023), compared with a mean of $340810.9.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 571.44% in 2024 and later crashed 90.97% in 2025.
  • LifeMD's Gains from Sales and Divestitures stood at $77875.0 in 2021, then skyrocketed by 127.45% to $177125.0 in 2022, then skyrocketed by 280.88% to $674625.0 in 2023, then skyrocketed by 115.56% to $1.5 million in 2024, then crashed by 86.25% to $200000.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $200000.0 (Q4 2025), $200000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.